CCL18 and primary cutaneous T-cell non-Hodgkin lymphoma: CCL18 plays a procancer role in most human cancers, including breast cancer [12], ovarian cancer [13], cutaneous T cell lymphoma, bladder cancer [14], prostate cancer [15], and pancreatic cancer [16], while patients with high CCL18 expression in gastric cancer [17] have better prognosis.